Logo Lanfrica

Dataset for "Polymeric microarray patches for transdermal delivery of amodiaquine and artesunate: A novel strategy against Plasmodium falciparum"

Domain:

healthcare

Record type:

dataset
Creator:
AnjDon
Editor:
AnjZANMiaMor
Publisher:
Que
Host:avatar
This is the dataset underpinning the peer-reviewed published paper entitled "Polymeric microarray patches for transdermal delivery of amodiaquine and artesunate: A novel strategy against Plasmodium falciparum." This article appears in Material Today Bio (Oct 2025). This dataset contains quantitative data generated from in vitro and in vivo experiments conducted to evaluate the drug delivery performance of microneedle and oral formulations of amodiaquine and artesunate for improved malaria therapy. Samples were analysed using high-performance liquid chromatography (HPLC-UV and HPLC-MS/MS) at the School of Pharmacy, Queen’s University Belfast, United Kingdom. The dataset supports the manuscript submitted to Materials Today Bio and ensures transparency and reproducibility of the reported findings. It may be useful to researchers in pharmaceutical sciences and drug delivery who are interested in antimalarial formulations, microneedle technologies, and chromatographic analysis. All data are provided in CSV format and can be opened using any standard spreadsheet or data analysis software.

Licenses

Creative Commons Attribution 4.0 Internationalhttps://creativecommons.org/licenses/by/4.0/legalcodeCreative Commons Attribution 4.0 Internationalhttps://creativecommons.org/licenses/by/4.0/legalcodeCreative Commons Attribution 4.0 Internationalhttps://creativecommons.org/licenses/by/4.0/legalcodeCreative Commons Attribution 4.0 Internationalhttps://creativecommons.org/licenses/by/4.0/legalcodeCreative Commons Attribution 4.0 Internationalhttps://creativecommons.org/licenses/by/4.0/legalcode+16

Similar

In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014

Efficacy of artesunate–amodiaquine, dihydroartemisinin–piperaquine and artemether–lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger

Abstract Background Malaria endemic countries need to assess ef

Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine and polymorphism in Plasmodium falciparum kelch13-propeller gene in Equatorial Guinea

International audience Background: Artesunate-amodiaquine (ASAQ) and artemether-lumef

Efficacy and safety of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated plasmodium falciparum malaria in South Sudan: a multi-site therapeutic efficacy study, 2024–2025

Selection of Pfcrt 76T and Pfmdr1 86Y Mutant Plasmodium falciparum after Treatment of Uncomplicated Malaria with Artesunate-Amodiaquine in Republic of Guinea

Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia.

International audience BACKGROUND: Safety surveillance of widely used artemisinin-bas